Dronedarone HCl is a salt form of dronedarone, which is a Class III antiarrhythmic and a multi-channel blocker for atrial fibrillation. It blocks potassium, sodium, and calcium channels and also exhibits antiadrenergic properties. In the United States, the FDA approved label includes a claim for reducing hospitalization, but not for reducing mortality, as a reduction in mortality was not demonstrated in the clinical development program.
Properties
Boiling Point: 683.9ºC at 760mmHg
Flash Point: 367.4ºC
Vapor Pressure: 1.47E-18mmHg at 25°C
Sodium Channel Inhibitors Related Products:
Carbamazepine; A-803467; Camostat Mesilate; Ambroxol hcl; Proparacaine hydrochloride; Rufinamide; Zonisamide; Zonisamide sodium salt; Baricitinib; Levobupivacaine; Levobupivacaine hcl; Vinpocetine; Propafenone hcl; Lamotrigine